Zum Inhalt

Correction to: Anti-inflammatory, anti-rheumatic and analgesic activities of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS) in rodents

  • 10.03.2018
  • Correction
Erschienen in:

Auszug

Unfortunately, Fig. 1 was incorrectly published in the original publication. The corrected Fig. 1 is given below.
Fig. 1
a Structure of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS). b MOPBS (1, 10, 50 and 100 mg/kg) pretreatment reduced carrageenan-induced paw oedema. The paw thickness was measured after 4 h of carrageenan injection. c MOPBS (1, 10, 50 and 100 mg/kg) pretreatment inhibited carrageenan-induced mechanical hyperalgesia, d mechanical allodynia and e thermal hyperalgesia. The paw withdrawal effect was measured after 4 h of carrageenan injection The data are expressed as the mean ± SD (*) p < 0.01, (**) p < 0.001 and (***) p < 0.0001 show a significant difference from carrageenan-induced group. (###) denotes comparison of vehicle control group (normal group) and carrageenan-induced group with MOPBS-treated group
Bild vergrößern
Titel
Correction to: Anti-inflammatory, anti-rheumatic and analgesic activities of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS) in rodents
Verfasst von
Hina Rasheed
Ruqayya Afridi
Ashraf Ullah Khan
Muhammad Zia Ullah
Sidra Khalid
Ayesha Atiq
Humaira Kashif
Muhammad Naeem Ahmed
Yeong Shik Kim
Salman Khan
Publikationsdatum
10.03.2018
Verlag
Springer International Publishing
Erschienen in
Inflammopharmacology / Ausgabe 4/2018
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-018-0461-5